New evidence for optimizing malaria treatment in pregnant women

(The Institute of Medical Science, The University of Tokyo) The research, published in The Lancet Infectious Diseases is the fruit of joint project between investigators from around the world to conduct the largest individual patient data meta-analysis to date under The WorldWide Antimalarial Resistance Network (WWARN) umbrella. The study found that artemether-lumefantrine (AL) and other artemisinin-based combination therapies (ACTs) were significantly more effective than quinine, the current recommended treatment. Authors urgently call for further investigation into dose optimization for pregnant women to ensure the highest possible treatment success.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news